Citations

Institution: Mayo Clinic Clear

Showing 10 of 108104 citations.

Next-Generation Approaches in Sports Medicine: The Role of Genetics, Omics, and Digital Health in Optimizing Athlete Performance and Longevity—A Narrative Review
Juginović, Alen , Kekić, Adrijana, Aranza, Ivan , Biloš, Valentina, Armanda, Mirko, Armanda, Mirko

Life | June 30, 2025 | Volume: 15 | Issue: 7 | Pages: 1023

10.3390/life15071023 | PMID 40724525 Get It

This review aims to provide a comprehensive framework for implementing precision sports medicine, integrating genetics, pharmacogenomics, digital health solutions, and multi-omics data. Literature review was conducted using MEDLINE, EMBASE, Web of Science, and Cochrane Library databases (January 2018–April 2024), focusing on precision medicine applications in sports medicine, utilizing key terms including “precision medicine”, “sports medicine”, “genetics”, and “multi-omics”, with forward and backward citation tracking. The review identified key gene variants affecting athletic performance: endurance (AMPD1, PPARGC1A), power (ACTN3, NOS3), strength (PPARG), and injury susceptibility (COL5A1, MMP3), while also examining inherited conditions like cardiomyopathies (MYH7, MYBPC3). Pharmacogenomic guidelines were established for optimizing common sports medications, including NSAIDs (CYP2C9), opioids (CYP2D6), and cardiovascular drugs (SLCO1B1, CYP2C19). Digital health technologies, including wearables and predictive analytics, showed potential for enhanced athlete monitoring and injury prevention, while multi-omics approaches integrated various molecular data to understand exercise capacity and injury predisposition, enabling personalized assessments, training regimens, and therapeutic interventions based on individual biomolecular profiles. This review provides sports medicine professionals with a framework to deliver personalized care tailored to each athlete’s unique profile, promising optimized performance, reduced injury risks, and improved recovery outcomes.
Transgender and gender diverse patients’ preference and comfort for having a medical chaperone present during a sensitive physical examination: a single-site study
Linder, Katie E, Ramirez, Johanna L., Pankey, Tyson, Heredia, Dagoberto , Chang, Alice Y. , Davidge‐Pitts, Caroline , Imhof, Nicole, González, César A. , Linder, K , Imhof, Nicole R, Gonzalez, Cesar , Linder, Katharine E

The Journal of Sexual Medicine | June 29, 2025 | Volume: 22 | Issue: 8 | Pages: 1504-1513

10.1093/jsxmed/qdaf147 | PMID 40581941 Get It

Abstract Background Medical chaperones are authorized individuals present during physical examinations involving the genitals, breasts/chest, or anal areas. The use of medical chaperones may provide an opportunity to improve transgender and gender diverse (TGD) patients’ experiences with sensitive examinations. Aim To examine TGD adult patients’ preferences and comfort for having a medical chaperone and whether TGD-specific characteristics, social anxiety symptoms, and feelings of medical mistrust are associated with preference for having a medical chaperone present during a sensitive physical examination. Methods This study used a cross-sectional survey that randomly sampled adult patients from a gender clinic in the Midwest region of the U.S. A total of 420 surveys were mailed. Sixty-two surveys were returned undeliverable, 358 reached recipients; 151 were returned (42.1% response rate). The survey included items related to demographics, gender-related anatomical dysphoria, social anxiety symptoms, feelings of medical mistrust, and preference and comfort towards medical chaperones. Results Among 149 respondents, 74 (49.7%) reported comfort for the idea of having a medical chaperone present during a sensitive physical examination, 50 (33.6%) reported neutral comfort, and 25 (16.8%) reported discomfort. Among 147 respondents, 89 (60.5%) endorsed a preference for a female medical chaperone. We found no associations between gender-related anatomical dysphoria or social anxiety symptoms and comfort for having a medical chaperone, or the gender preference for a medical chaperone. Medical mistrust was associated with lower comfort with having a medical chaperone present during a sensitive physical examination. Clinical Implications Routinely offering medical chaperones, especially female chaperones, is like to be generally acceptable to most TGD patients. These findings may inform clinic policies on providing medical chaperones during sensitive examinations. Strengths and Limitations This study is the first to examine TGD preferences for medical chaperones. Findings are limited by a single site, homogeneous sample, cross-sectional design, and reliance on hypothetical rather than observed examinations. Conclusion TGD adults report comfort with the concept of having a medical chaperone during sensitive examinations and most would prefer the chaperone to be female. Preference for having a medical chaperone present during a sensitive physical exam is not likely influenced by gender dysphoria or social anxiety.
Comparison of Frontline Therapies in Older Adults Age ≥ 80 Years With Chronic Lymphocytic Leukemia (CLL): A Mayo Clinic and Danish Nation‐Wide Study
Tsang, Mazie , Hampel, Paul J. , Rabe, Kari G. , Ding, Wei , Leis, José F., Kenderian, Saad S. , Wang, Yucai , Muchtar, Eli , Koehler, Amber B. , Dyke, Daniel L. Van , Hanson, Curtis A. , Hjalgrim, Henrik , Ding, Wei , Kenderian, Saad Sirop , Wang, Yucai , Muchtar, E , Van Dyke, Daniel L, Shi, Min , Parikh, Sameer A , Chaffee, Kari G. , Tsang, Mazie , Brieghel, Christian , Hilal, Talal , Slager, Susan L. , Kay, Neil E. , Niemann, Carsten Utoft , Parikh, Sameer A. , Rotbain, Emelie Curovic

American Journal of Hematology | June 29, 2025 | Volume: 100 | Issue: 9 | Pages: 1678-1681

10.1002/ajh.27747 | PMID 40530575 Get It

Immune checkpoint inhibitor myocarditis—a score to tell you more
Herrmann, Joerg , Lyon, Alexander R, Lyon, Alexander R.

European Heart Journal | June 29, 2025 | Volume: 47 | Issue: 9 | Pages: 1063-1065

10.1093/eurheartj/ehaf503 | PMID 40748650 Get It

Predictors of Permanent Pacemaker Implantation Following Valve-In-Valve Transcatheter Aortic Valve Replacement
Quelal, Karol , Arya, Namrata , Sugrue, Alan , Cha, Yong‐Mei , Eleid, Mackram F. , Deshmukh, Abhishek , Quelal, Karol , Donisan, Teodora , Harmon, David , Alkhouli, Mohamad

No container title available | June 29, 2025 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.22541/au.175117683.36581994/v1 Get It

Background Valve-in-valve transcatheter aortic valve replacement (ViV-TAVR) is increasingly used to treat structural valve degeneration. Permanent pacemaker implantation (PPI) following TAVR is associated with increased morbidity and mortality, yet predictors specific to ViV-TAVR remain poorly defined. Objective To identify clinical and procedural predictors of PPI in patients undergoing ViV-TAVR. Methods We conducted a retrospective observational study of consecutive ViV-TAVR cases at the Mayo Clinic from 2012 to 2022. Clinical, ECG, procedural data and fluoroscopic measurements were analyzed, and propensity score matching was used to adjust for confounding. Predictors of PPI were identified using multivariable logistic regression. Results Among 261 patients, 24 (9.2%) required PPI. Balloon-expandable valves were used in 66.7% and self-expanding valves in 33.3%. Predictors of PPI included pre-procedural bifascicular block (OR 12.15, 95% CI: 2.52–68.89, p=0.003), greater septal implantation depth (OR 1.29, 95% CI: 1.04–1.65, p=0.019), and post-procedural new left (OR 23.56, 95% CI: 4.91–48.52, p=0.0004) and right bundle branch blocks (OR 24.4, 95% CI: 3.82–30.51, p=0.001). Aortic regurgitation as the mechanism of prosthetic valve failure was associated with reduced PPI odds (OR 0.28, 95% CI: 0.10–0.76, p=0.014). Pacing requirement—defined as >90% ventricular pacing—increased from 25% at 3 months to 56.25% at 12 months. At a median follow-up of 962.5 days (IQR 481.5–1555.3), adjusted mortality was significantly higher in the PPI group (aOR 9.4, 95% CI: 1.9–60.4, p=0.028). Conclusion Bifascicular block, greater septal depth, and new bundle branch blocks predict PPI post-ViV-TAVR, while aortic regurgitation appears protective. Risk stratification and procedural planning are critical.
Epigenetic Context Defines the Transcriptional Activity of Canonical and Noncanonical NF-κB Signaling in Pancreatic Cancer
Aggrey-Fynn, Joana E., Busch, Joshua, Saul, Dominik , Rajput, Ashish , Willecke, Kerstin, Klimt, Nicole, Rajendran, Kothai, Schacherer, Nadine , Ge, Wanwan , Truty, Mark J. , Saul, Dominik , Aggrey-Fynn, Joana , Busch, Joshua, Rajput, Ashish, Rajendran, Kothai, Thiel, Julia , Abdelrahman, Amro M , Dong, Meng , Johnsen, Steven A.

No container title available | June 28, 2025 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1101/2025.06.25.661561 Get It

Abstract NF-κB signaling can be subdivided into canonical and noncanonical pathways, culminating in the transcriptional activity of RELA and RELB, respectively. However, the upstream signals that activate these transcription factors and their specific regulatory roles in pancreatic ductal adenocarcinoma (PDAC) remain incompletely understood. Here, we demonstrate that TNFα is the primary activator of canonical NF-κB signaling via RELA, while TWEAK engages noncanonical signaling through RELB in PDAC. Using transcriptome-wide gene expression, genome-wide occupancy profiling, and epigenome mapping, we delineate distinct temporal dynamics and regulatory activities of each pathway. Single-cell RNA-seq analysis and multiplex immunofluorescence staining in primary PDAC samples further reveal extensive and distinct interactions with components of the tumor microenvironment. Motif analysis of RELA- and RELB-bound regions uncovers a particularly strong association of RELB with AP1 elements. Notably, while RELA binds to both open and closed chromatin, RELB exclusively occupies regions with pre-existing chromatin accessibility and AP1 co-binding. Collectively, these findings underscore the distinct and complementary roles of TNFα and TWEAK in PDAC, with TNFα engaging a broader transcriptional program via RELA and TWEAK selectively targeting genes marked by accessible chromatin and epigenetic activity. This study provides critical insights into the regulatory dynamics of NF-κB signaling in PDAC, highlighting unique and complementary functions of RELA and RELB in modulating downstream gene expression. Significance TNFα and TWEAK selectively activate RELA and RELB in pancreatic cancer, revealing that RELB-driven noncanonical signaling depends on chromatin accessibility and AP-1, uncovering distinct, targetable epigenetic dependencies from canonical signaling. Graphical abstract
Weight Loss With Topiramate and Phentermine Combination Therapy in a Patient With Bardet-Biedl Syndrome
Hassan, Doha , Salama, Mostafa , Kumar, Seema , Muthusamy, Kalpana , Salama, Mostafa

JCEM Case Reports | June 28, 2025 | Volume: 3 | Issue: 9 | Pages: No page available

10.1210/jcemcr/luaf164 | PMID 40741596 Get It

Abstract There is limited data on the effect of antiobesity medications in individuals with Bardet-Biedl syndrome (BBS). Here, we present a case of an adult with BBS who experienced significant weight loss following treatment with a combination of topiramate and phentermine. A 31-year-old female with BBS, with homozygous pathogenic variant in the BBS2 gene, presented with obesity, dyslipidemia, and obstructive sleep apnea. At 29 years of age, her body mass index (BMI) was 43.3 kg/m2 (reference range 18.5-24.9 kg/m2), and she was initiated on 50 mg topiramate daily for migraine prophylaxis. With lifestyle modifications, BMI dropped to 40.5 kg/m2. Subsequently, phentermine 30 mg daily was added. Eight months after adding phentermine, BMI significantly decreased to 31.5 kg/m² (27% decrease in BMI), with improvement in glycemic and lipid parameters. She developed paranoia due to a social stressor prompting a brief hold of phentermine and resumption at a lower dose. This case highlights the weight loss response with phentermine and topiramate combination therapy in a patient with BBS. Further research is needed to explore the efficacy and safety of conventional antiobesity medications in isolation, as sequential or combination therapy to setmelanotide, to most effectively impact weight and metabolic burden in patients with BBS.
An Observational Analysis of a Large Cohort of Pneumocystis jirovecii Pneumonia
Pulsipher, Aaron M. , Vikram, Holenarasipur R. , Gotway, Michael B. , Cartin‐Ceba, Rodrigo , Henry, Kyle J, Johnson, Alec M, Gassner, Ryan R , Zhou, Kevin , Green, D., Thompson, Emily , Sen, Ayan , Lee, Augustine S. , Ham, Kealy R., Green, Danielle , Thompson, Emily R , Sen, Ayan , Lee, Augustine S , Ham, Kealy , Vikram, Holenarasipur R. , Gotway, Michael B , Pulsipher, Aaron M , Henry, Kyle J, Johnson, Alec M, Limper, Andrew H.

Open Forum Infectious Diseases | June 28, 2025 | Volume: 12 | Issue: 7 | Pages: No page available

10.1093/ofid/ofaf390 | PMID 40708624 Get It

Abstract Background Pneumocystis jirovecii pneumonia (PCP) is increasingly seen in patients who are non-HIV immunocompromised hosts, yet modern risk factors and outcomes are poorly recognized and defined. Methods A retrospective review was conducted of adult patients who met criteria for proven or probable PCP from 2017 to 2024 across a large academic multicenter health system. The primary outcome was mortality among cohorts, defined by etiology of immunosuppression through univariate and age-adjusted logistic regression. Secondary analyses included trends in annual diagnoses and testing patterns. Results A total of 701 patients met criteria for inclusion, representing one of the largest clinically characterized cohorts of PCP to date. The median age was 65 years (IQR, 54–73) and 62% were male. The most common risk groups were hematologic malignancy (32.2%), solid tumor cancers receiving chemotherapy (22.4%), and autoimmune disease with immunosuppression (17.7%). Annual PCP diagnoses increased at a rate of 15.8% (95% CI, 8.9%–23.2%) in parallel with increased testing. Only 5.4% of patients were receiving prophylaxis at the time of diagnosis. Overall mortality was 20% (95% CI, 17%–23%) and highest in cirrhosis (adjusted odds ratio, 6.24; 95% CI, 2.84–13.69; P < .001). Conclusions PCP in the current era affects a broad range of patients who are immunocompromised, with high associated mortality and low rates of prophylaxis. Patients with solid tumors and those with cirrhosis are at particularly high risk of mortality. These findings highlight the need to reassess and redefine PCP prophylaxis guidelines in specific populations and our understanding of who is at risk.
Violet Education Bundle for Workplace Violence: A Quality Improvement Project
Armstead, Madeline , Ward, Bethany , Busch, Ashley, Hoiem, Jennifer, Ward, Bethany , Busch, Ashley

Journal of the American Psychiatric Nurses Association | June 28, 2025 | Volume: 31 | Issue: 5 | Pages: 570-577

10.1177/10783903251347660 | PMID 40579939 Get It

Introduction: Workplace violence (WPV) in healthcare is detrimental to staff and institutions. The prevalence of events continues to increase despite efforts to mitigate events. WPV is associated with psychological and physical consequences and has been attributed to healthcare workers leaving the field, further contributing to the shortage of frontline healthcare staff. Healthcare workers often underreport WPV events due to cultures of acceptance, lack of knowledge of resources, and feeling unsupported during or after an event. Aim: This quality improvement project aimed to implement a WPV bundle and evaluate the effectiveness of staff utilization of WPV resources, perceived confidence, knowledge, and support during and after WPV events in a general surgery unit. Method: A hybrid education bundle, named the Violet Education Bundle, includes education for nurses on de-escalation techniques, incident reporting, standardization of shift-change huddle reporting, and resources for psychological support. A single-group, pre- and post-test design was utilized, and a paired t -test was employed to test for statistical significance. Results: With 23.2% of staff ( N = 20) completing both the pre-/post-survey (support, confidence, knowledge, and resource utilization sections) at both time points, no pre- to post-implementation outcome increases were statistically significant. Conclusion: Though the 60-day follow-up might have contributed to the null findings, nurses anecdotally expressed that they found the resources valuable and appreciated having them in one place. Future research should include an assessment of effectiveness for improving staff confidence, knowledge, perceived support, and reduced incidence and complications of WPV events over a sustained period of time.
OnabotulinumtoxinA Injections for Atypical Site Hyperhidrosis
Ngo, Hannah P. , Campbell, Elliott H. , Demer, Addison M. , Vidal, Nahid Y. , Reinhart, Jacob P.

International Journal of Dermatology | June 27, 2025 | Volume: 64 | Issue: 11 | Pages: 2164-2165

10.1111/ijd.17931 | PMID 40579736 Get It